These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 30798354)

  • 1. α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.
    Sorrentino ZA; Giasson BI; Chakrabarty P
    Acta Neuropathol; 2019 Jul; 138(1):1-21. PubMed ID: 30798354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons and Glia Interplay in α-Synucleinopathies.
    Mavroeidi P; Xilouri M
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
    Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
    Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.
    Sorrentino ZA; Goodwin MS; Riffe CJ; Dhillon JS; Xia Y; Gorion KM; Vijayaraghavan N; McFarland KN; Golbe LI; Yachnis AT; Giasson BI
    Acta Neuropathol Commun; 2019 Sep; 7(1):142. PubMed ID: 31477175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
    Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
    Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
    J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.
    Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H
    Neuropharmacology; 2003 Jul; 45(1):14-44. PubMed ID: 12814657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
    Wales P; Pinho R; Lázaro DF; Outeiro TF
    J Parkinsons Dis; 2013; 3(4):415-59. PubMed ID: 24270242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into cellular α-synuclein homeostasis in health and disease.
    Dettmer U; Selkoe D; Bartels T
    Curr Opin Neurobiol; 2016 Feb; 36():15-22. PubMed ID: 26282834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Modes of Intercellular α-Synuclein Transmission.
    Valdinocci D; Radford RA; Siow SM; Chung RS; Pountney DL
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synucleinopathy phenotypes.
    McCann H; Stevens CH; Cartwright H; Halliday GM
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S62-7. PubMed ID: 24262191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New α- and γ-synuclein immunopathological lesions in human brain.
    Surgucheva I; Newell KL; Burns J; Surguchov A
    Acta Neuropathol Commun; 2014 Sep; 2():132. PubMed ID: 25209836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
    Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
    Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity.
    Sorrentino ZA; Brooks MMT; Hudson V; Rutherford NJ; Golde TE; Giasson BI; Chakrabarty P
    Mol Neurodegener; 2017 May; 12(1):40. PubMed ID: 28552073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological biochemistry of alpha-synucleinopathy.
    Iwatsubo T
    Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of α-synuclein truncation in aggregation and disease.
    Sorrentino ZA; Giasson BI
    J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation.
    Tsunemi T; Ishiguro Y; Yoroisaka A; Valdez C; Miyamoto K; Ishikawa K; Saiki S; Akamatsu W; Hattori N; Krainc D
    J Neurosci; 2020 Nov; 40(45):8618-8628. PubMed ID: 33046546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the spectrum of neuronal pathology in multiple system atrophy.
    Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
    Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.